2022-11-11T08:17:55-06:00 2021-12-31 410746749 CLIFTONLARSONALLEN LLP TWO INTERNATIONAL PLACE 22ND FLOOR BOSTON MA 02110 990 2021-04-01 131949477 NEW YORK BLOOD CENTER INC NEWY 2125703100 310 EAST 67TH STREET NEW YORK NY 10065 JOSEPH S MOHR CFO 2125703100 2022-11-15 1 JOSEPH MOHR XXX-XX-XXXX LAURA J KENNEY P00202198 6177170831 2022-11-02 3 AAL1 IAL1 2021 2022-09-23 18:48:47Z DR CHRISTOPHER HILLYER 310 EAST 67TH STREET NEW YORK NY 10065 398494268 0 X NYBLOODCENTER.ORG X 1959 NY AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THE WORLD, NEW YORK BLOOD CENTER OPERATES UNDER A FOUR-PART MISSION.SPECIFICALLY, NYBC EXISTS:- TO PROVIDE THE HIGHEST QUALITY BLOOD AND STEM CELL PRODUCTS AND RELATED MEDICAL AND CONSULTATIVE SERVICES TO HOSPITALS AND PATIENTS.- TO CONDUCT THE HIGHEST QUALITY, NOVEL AND INNOVATIVE RESEARCH IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING AND TRANSFUSION MEDICINE, AND CELLULAR THERAPIES, THUS ADVANCING THESE FIELDS AND POSITIVELY IMPACTING THE PUBLIC HEALTH- TO DEVELOP PRODUCTS, TECHNOLOGIES, AND SERVICES IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING, AND TRANSFUSION MEDICINE AND CELLULAR THERAPIES, WITH THE POTENTIAL TO HAVE WORLDWIDE HUMANITARIAN IMPACT- TO TRAIN THE NEXT GENERATION OF LEADERS IN EACH OF THESE FIELDS 20 19 2699 730 0 0 24165905 12767729 528661629 376487315 881408 1786143 1006876 961506 554715818 392002693 46761 96018 0 0 190883146 151877885 0 0 222953 316165078 235730610 507094985 387704513 47620833 4298180 653903495 819022618 98848143 221102670 555055352 597919948 AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THEWORLD, NYBC OPERATES UNDER A FOUR-PART MISSION. FOR MORE INFORMATION,SEE SCH. O AND PART III, 4A-C. 0 0 223168000 96018 251399130 BLOOD SERVICES: THE COLLECTION AND PROCESSING OF BLOOD PRODUCTS,TESTING OF BLOOD SAMPLES AND THE DISTRIBUTION OF THESE PRODUCTS TOHOSPITALS IN THE REGIONS SERVED BY NYBCE DIVISIONS. 117867000 125088185 MEDICAL PROGRAMS: PROGRAMS INCLUDE (1) CLINICAL SERVICES(INCLUDING TRANSFUSION THERAPY SERVICES); (2) BONE MARROW PROGRAM;AND (3) HEMOPHILIA SERVICES CONSORTIUM.NATIONAL CORD BLOOD PROGRAM: THE COLLECTION, PROCESSING ANDSTORAGE OF CORD BLOOD UNITS AND THE DISTRIBUTION OF THESE UNITSFOR TREATMENT OR FOR RESEARCH PURPOSES. 11848832 RESEARCH PROGRAM: THE NEW YORK BLOOD CENTER OPERATES AWIDE-RANGING PROGRAM OF RESEARCH INTO THE PROPERTIES OF BLOOD ANDBLOOD RELATED DISEASES. 352883832 1 1 0 1 0 0 0 0 0 0 1 1 0 1 1 1 1 0 0 0 1 0 0 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 639 0 1 2699 1 1 1 0 0 0 0 0 0 0 0 0 1 0 X 20 19 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA FL IL MA MD MI MN NC NJ NY PA RI TN VA WI X JOSEPH S MOHR 2125703016 310 EAST 67TH STREET NEW YORK NY 10065 X CHRISTOPHER HILLYER PRESIDENT & CHIEF EXECUTIVE OFFICER 50.00 X X 1981392 0 104313 MARC KRAMER CHAIR 1.00 X X 0 0 0 MARK SCHMIDTLEIN VICE CHAIR OF EXECUTIVE COMMITTEE 1.00 X X 0 0 0 AVERY AUGUST TRUSTEE 1.00 X 0 0 0 JUNG CHOI TRUSTEE 1.00 X 0 0 0 YVES DENIZE TRUSTEE 1.00 X 0 0 0 DAVID DRISCOLL TRUSTEE 1.00 X 0 0 0 PHILIP FALIVENE TRUSTEE 1.00 X 0 0 0 JOHN FERRETTI TRUSTEE 1.00 X 0 0 0 ARIEL FISHMAN TRUSTEE 1.00 X 0 0 0 OWEN GARRICK TRUSTEE 1.00 X 0 0 0 PETER LOPEZ TRUSTEE 1.00 X 0 0 0 AARON MARCU TRUSTEE 1.00 X 0 0 0 THERESA RAGOZINE TRUSTEE 1.00 X 0 0 0 CHARLES REPPUCCI TRUSTEE 1.00 X 0 0 0 JOHN ROSENTHAL TRUSTEE 1.00 X 0 0 0 JAIME SHAMONKI TRUSTEE 1.00 X 0 0 0 ROBERT SCHWARTZ TRUSTEE 1.00 X 0 0 0 PAUL TORGERSON TRUSTEE 1.00 X 0 0 0 STEPHEN WURTZLER TRUSTEE 1.00 X 0 0 0 ELIZABETH MCQUAIL EVP - OPS & MANUFACTURING/COO 50.00 X 826488 0 41835 JOSEPH MOHR CHIEF FINANCIAL AND BUSINESS OFFICER 50.00 X 553073 0 55059 ROBERT PURVIS CHIEF OF STAFF 50.00 X 509624 0 52563 JORDANA SCHWARTZ SVP - GENERAL COUNSEL/SECRETARY 50.00 X 465763 0 54838 BETSY JETT SVP - CHIEF QUAL & REGULATORY OFFICER 50.00 X 466046 0 31433 BRUCE SACHAIS VP - CHIEF MEDICAL OFFICER 50.00 X 395678 0 54110 BERNADETTE TISO DEPUTY GENERAL COUNSEL/ASST SECRETARY 50.00 X 269608 0 53574 BARRY GREENE VP - CHIEF ADMINISTRATION OFFICER 50.00 X 272065 0 40668 SHAKIMA WELLS ASSOCIATE GENERAL COUNSEL, ASSISTANT SECRETARY 50.00 X 140027 0 28340 PATRICIA KILLEEN VP - ENTERPRISE BLOOD OPERATIONS OPTIMIZATION 50.00 X 355139 0 44078 DONNA STRAUSS VP - ENTERPRISE LABORATORY SERVICES 50.00 X 344766 0 52096 JED GORLIN VP - MEDICAL & REGULATORY AFFAIRS 50.00 X 355069 0 31580 DAVID GRAHAM VP - NYBC DIVISIONS 50.00 X 322758 0 49985 JOON MOON EXECUTIVE DIRECTOR, CONTROLLER ENTERPRISE 50.00 X 291675 0 63228 DEBRA KESSLER VP - MEDICAL PROGRAMS & SERVICES 50.00 X 269264 0 50722 MONIQUE BROWN GEORGE VP - HUMAN RESOURCES 50.00 X 255326 0 31321 DARLENE FOLAN VP - QUALITY ASSURANCE 50.00 X 230133 0 11108 MARK JANZEN VP - LABORATORY SERVICES 50.00 X 168115 0 37228 LARRY LUCHSINGER VP - DIRECTOR RESEARCH OPERATIONS 50.00 X 165035 0 30482 MOHANDAS NARLA VP - LFRKI 50.00 X 367804 0 44078 CONNIE WESTHOFF EXECUTIVE SCIENTIFIC DIRECTOR- IMMUNOHEMATOLOGY 50.00 X 357597 0 42399 JEANNIE MASCOLINO SR. EXECUTIVE DIRECTOR-BLOOD COLLECTIONS 50.00 X 311435 0 53895 NANCY VAN BUREN ASSOCIATE MEDICAL DIRECTOR 50.00 X 286913 0 42172 KARINA YAZDANBAKHSH VP - DIRECTOR, RESEARCH DEV. LFKRI 50.00 X 276308 0 28851 10237101 0 1129956 240 0 1 0 INCEPT CORPORATION 4150 BELDEN VILLAGE STREET CANTON OH 44718 BLOOD DONOR MARKETING 3209776 ATOS IT SOLUTIONS AND SERVICE PO BOX 710878 COLUMBUS OH 43271 IT SERVICES 2688919 DOUGHERTY CLIFFORD & WADSWORTH CORPORAT 895 MARCONI AVENUE RONKONKOMA NY 11779 MARKETING SERVICES 2665100 CROSSROADS COURIER 2008 ALTOM CT SAINT LOUIS MO 63146 MESSENGER 2079112 MARKHAM AND STEIN UNLIMITED 2424 SOUTH DIXIE HIGHWAY 3RD FLOOR MIAMI FL 33133 MARKETING SERVICES 1803490 65 12351347 416382 59905 12767729 BLOOD SERVICES 621500 251399130 251399130 MEDICAL PROGRAMS 621500 125088185 125088185 376487315 451718 451718 961506 0 961506 961506 961506 5815000 2011000 4813833 1677742 1001167 333258 1334425 1334425 392002693 376487315 0 2747649 24694 24694 71324 71324 9431808 1131817 8299991 104814198 98309952 6437905 66341 4184170 3959164 221012 3994 25822675 24045434 1762430 14811 7625034 6834032 786599 4403 1377048 276135 1100913 241922 241922 664413 664413 2197203 2197203 6813741 5301617 1423712 88412 1624458 1599695 23995 768 685578 651786 33792 6943275 4804234 2139041 12321155 9055530 3264258 1367 748179 738949 9230 655751 655751 11369236 8262088 3107148 2873132 2224512 648620 SUPPLIES 150759196 150699376 59820 R&M & EQUIPMENT 9391808 7985168 1406640 MGMT FEE-HEMOPHILIA CON 8877412 8877412 COURIER/DELIVERY SERVIC 5841448 5841277 171 12345655 10869472 1433326 42857 387704513 352883832 34597728 222953 57051493 67043932 26566757 638260 79719744 68618283 29632026 34983628 6027493 5122267 308871921 213391156 96795441 95480765 1136798 1110391 337210440 397038436 19763303 148986656 653903495 819022618 75427912 55213705 3171603 0 6978114 7027086 8983672 7275208 4286842 151586671 98848143 221102670 X 554850124 597287659 205228 632289 555055352 597919948 653903495 819022618 4298180 38566417 0 X 0 1 X 1 1 1 X 12883405 13590606 13809977 24165905 12767729 77217622 321238027 346596532 437376620 528661629 376487315 2010360123 334121432 360187138 451186597 552827534 389255044 2087577745 138183 104344 120000 44804 28000 435331 0 138183 104344 120000 44804 28000 435331 2087142414 8505075 11907059 6483089 1550871 1413224 29859318 8505075 11907059 6483089 1550871 1413224 29859318 342626507 372094197 457669686 554378405 390668268 2117437063 0.98570 0.98160 0.01410 0.01780 X SCHEDULE A, PART III THE ORGANIZATION CHANGED ITS YEAR END AND COLUMN (E) IS FOR A SHORT YEAR APRIL 1, 2021 THROUGH DECEMBER 31, 2021. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 664413 664413 387040101 387704514 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 197900 511873 584773 664413 1958959 250000 250000 250000 250000 1000000 1500000 17121175 17121175 122618258 74074908 48543350 104196097 102795738 1400359 64936391 36520510 28415881 95480765 INVESTMENT ACCOUNT 4667104 F INVESTMENT FUNDS 392371332 F 397038436 RIGHT OF USE ASSET 148083727 OTHER ASSETS 902929 148986656 FMV OF INTEREST RATE SWAP 621396 OTHER CURRENT LIABILITIES 2018999 OTHER LONG TERM LIABILITIES 152112 CAPITAL LEASES - ROU LIABILITY 148794164 151586671 X 391674975 124000 124000 391550975 451718 451718 392002693 386866894 0 386866894 451718 385902 837620 387704514 PART X, LINE 2: THE ORGANIZATION HAS BEEN DETERMINED BY THE INTERNAL REVENUE SERVICE TO BE A NONPROFIT CORPORATION, EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). AS A NONPROFIT CORPORATION, THE ORGANIZATION IS ALSO EXEMPT FROM STATE AND LOCAL INCOME TAXES. THE ORGANIZATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO THE ORGANIZATION'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER IRC SECTION 511. THERE WAS NO UNRELATED BUSINESS INCOME TAX LIABILITY FOR THE PERIOD AND YEAR ENDED DECEMBER 21, 2021 AND MARCH 31, 2021, RESPECTIVELY. PART XI, LINE 2D - OTHER ADJUSTMENTS: NET ASSETS RELEASED FROM DONOR RESTRICTION 124,000. PART XII, LINE 4B - OTHER ADJUSTMENTS: LOSS ON SWAP 385,902. CENTRAL AMERICA AND THE CARIBBEAN - ANTIGUA & BARBUDA, ARUBA, BAHAMAS, 0 0 INVESTMENTS 2411596 0 0 0 0 0 0 2411596 0 2411596 0 0 1 1 1 0 PART III ACCOUNTING METHOD: 1 AABB NBF 8101 GLENBROOK RD BETHESDA MD 20814 362384118 501(C)(6) 10000 0 CONFERENCE AND EXPO SPONSORSHIP 0 1 COLLEGE SCHOLARSHIPS 184 71324 PART I, LINE 2 NYBC HAS PROVIDED FINANCIAL ASSISTANCE, RATHER THAN GRANTS, TO THE ORGANIZATION LISTED IN PART I. THIS ASSISTANCE IS CONSISTENT WITH NYBC'S CHARITABLE MISSION. PART III COLLEGE SCHOLARSHIPS ARE AWARDED TO STUDENTS WHO VOLUNTEER THEIR TIME AT BLOOD DRIVES IN THE FURTHERANCE OF NYBC'S MISSION. X X X X X 0 1 0 0 0 0 0 1 0 CHRISTOPHER HILLYER PRESIDENT & CHIEF EXECUTIVE OFFICER 1049892 0 850000 0 81500 0 69300 0 35013 0 2085705 0 47950 0 ELIZABETH MCQUAIL EVP - OPS & MANUFACTURING/COO 691832 0 101839 0 32817 0 29000 0 12835 0 868323 0 0 0 JOSEPH MOHR CHIEF FINANCIAL AND BUSINESS OFFICER 509380 0 43693 0 0 0 20300 0 34759 0 608132 0 0 0 ROBERT PURVIS CHIEF OF STAFF 450321 0 54418 0 4885 0 20300 0 32263 0 562187 0 0 0 JORDANA SCHWARTZ SVP - GENERAL COUNSEL/SECRETARY 434380 0 22184 0 9199 0 20300 0 34538 0 520601 0 0 0 BETSY JETT SVP - CHIEF QUAL & REGULATORY OFFICE 418004 0 41002 0 7040 0 20300 0 11133 0 497479 0 0 0 BRUCE SACHAIS VP - CHIEF MEDICAL OFFICER 366550 0 29128 0 0 0 20300 0 33810 0 449788 0 0 0 MOHANDAS NARLA VP - LFRKI 367804 0 0 0 0 0 20300 0 23778 0 411882 0 0 0 CONNIE WESTHOFF EXECUTIVE SCIENTIFIC DIRECTOR- IMMUN 340738 0 16859 0 0 0 20300 0 22099 0 399996 0 0 0 PATRICIA KILLEEN VP - ENTERPRISE BLOOD OPERATIONS OPT 311874 0 43265 0 0 0 20300 0 23778 0 399217 0 0 0 DONNA STRAUSS VP - ENTERPRISE LABORATORY SERVICES 322401 0 22365 0 0 0 29000 0 23096 0 396862 0 0 0 JED GORLIN VP - MEDICAL & REGULATORY AFFAIRS 335110 0 19959 0 0 0 11600 0 19980 0 386649 0 0 0 DAVID GRAHAM VP - NYBC DIVISIONS 301758 0 21000 0 0 0 19950 0 30035 0 372743 0 0 0 JEANNIE MASCOLINO SR. EXECUTIVE DIRECTOR-BLOOD COLLECT 297111 0 14324 0 0 0 29000 0 24895 0 365330 0 0 0 JOON MOON EXECUTIVE DIRECTOR, CONTROLLER ENTER 272865 0 18810 0 0 0 28215 0 35013 0 354903 0 0 0 NANCY VAN BUREN ASSOCIATE MEDICAL DIRECTOR 275768 0 11145 0 0 0 11600 0 30572 0 329085 0 0 0 BERNADETTE TISO DEPUTY GENERAL COUNSEL/ASST SECRETAR 259185 0 10423 0 0 0 18815 0 34759 0 323182 0 0 0 DEBRA KESSLER VP - MEDICAL PROGRAMS & SERVICES 253928 0 15336 0 0 0 26011 0 24711 0 319986 0 0 0 BARRY GREENE VP - CHIEF ADMINISTRATION OFFICER 261601 0 10464 0 0 0 18569 0 22099 0 312733 0 0 0 KARINA YAZDANBAKHSH VP - DIRECTOR, RESEARCH DEV. LFKRI 276308 0 0 0 0 0 27517 0 1334 0 305159 0 0 0 MONIQUE BROWN GEORGE VP - HUMAN RESOURCES 237754 0 17572 0 0 0 17143 0 14178 0 286647 0 0 0 DARLENE FOLAN VP - QUALITY ASSURANCE 212043 0 18090 0 0 0 0 0 11108 0 241241 0 0 0 MARK JANZEN VP - LABORATORY SERVICES 155751 0 12364 0 0 0 6667 0 30561 0 205343 0 0 0 LARRY LUCHSINGER VP - DIRECTOR RESEARCH OPERATIONS 165035 0 0 0 0 0 11166 0 19316 0 195517 0 0 0 SHAKIMA WELLS ASSOCIATE GENERAL COUNSEL, ASSISTANT 133622 0 6405 0 0 0 9944 0 18396 0 168367 0 0 0 PART I, LINE 4B THE INDIVIDUALS LISTED BELOW PARTICIPATED IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN. PAYMENTS WERE VESTED AND RECEIVED IN 2021 AND INCLUDABLE IN INCOME. - CHRISTOPHER HILLYER - $68,500 - ELIZABETH MCQUAIL - $32,817 - JORDANA SCHWARTZ - $9,199 - BETSY JETT - $7,040 - ROBERT PURVIS - $4,885 THE ORGANIZATION HAS A SECTION 457(F) PLAN FOR THE CEO. THE ORGANIZATION PROVIDED $49,000 FOR THE PLAN IN TAX YEAR 2021, REPORTED IN SCHEDULE J, PART II, COLUMN (C). THE DEFERRED COMPENSATION IS SUBJECT TO A SUBSTANTIAL RISK OF FORFEITURE. PART I, LINE 7 UPON THE ORGANIZATION ACHIEVING CERTAIN BUDGET THRESHOLDS, EXECUTIVES OTHER THAN THE CEO WERE ELIGIBLE FOR MERIT BONUSES OF UP TO 10% OF THEIR ANNUAL BASE SALARIES, DETERMINED BY THEIR ACHIEVING PERFORMANCE BENCHMARKS ESTABLISHED BY SENIOR MANAGEMENT AND APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD. THE CEO'S ANNUAL BONUS IS DISCRETIONARY DETERMINED BY THE BOARD AND BASED ON PERFORMANCE. A RHODE ISLAND HEALTH AND EDUCATIONAL BUILDING CORPORATION 521300173 2012-06-29 9000000 CONSTRUCTION OF AN ADDITION & RENOVATION OF FACILITIES 0 0 0 A 9000000 98450 8497647 403903 2014 0 0 1 1 A 0 0 0 0 0.00000 0.00000 0.00000 0 0 1 A 0 0 1 0 0 0 0 0 1 A 1 SCHEDULE K, PART I, BOND ISSUES PROCEEDS FROM THE BOND WERE TO BE USED TO FINANCE THE ACQUISITION, CONSTRUCTION, EQUIPPING AND FURNISHING OF A 20,000 SQUARE FOOT ADDITION ADJACENT TO THE MAIN FACILITY. THE ADDITION HOUSES THE ORGANIZATION'S OPERATIONAL REGULATORY FUNCTIONS, INCLUDING LABORATORIES AND DISTRIBUTION FUNCTIONS. IN ADDITION, RENOVATIONS AND IMPROVEMENTS WERE MADE TO THE ORGANIZATION'S MAIN FACILITY LOCATED AT 405 PROMENADE ST, PROVIDENCE, RI. SCHEDULE K, PART II , LINE 11 THE PROCEEDS FROM THE BOND ISSUE WERE PROVIDED IN THE FORM OF A DRAW DOWN FACILITY FROM WHICH PROCEEDS COULD BE DRAWN DOWN UNTIL MARCH 29, 2014. ALL AMOUNTS DRAWN WERE USED FOR CAPITAL EXPENDITURES AND BOND ISSUANCE COSTS IN THE AMOUNTS AS DESCRIBED ABOVE. ON MARCH 29, 2014, THE DRAW DOWN FACILITY CONVERTED TO A LOAN PAYABLE REQUIRING PRINCIPAL AND INTEREST PAYMENTS. AT THE CONVERSION DATE, THE TOTAL OUTSTANDING BORROWINGS AMOUNTED TO $8,596,097. A PREPAYMENT WAS MADE ON THE BOND FOR THE BALANCE OF THE BOND ISSUE, $403,903. X 6 36634 COST X EVENT TICKETS 3 23271 COST 0 1 0 990 SCHEDULE M PART I LINE 19 THE NUMBER OF NON-CASH CONTRIBUTIONS RECEIVED IS REPORTED IN COLUMN (B). FORM 990, PART VI, SECTION B, LINE 11B FOLLOWING COMPLETION OF THE FINANCIAL AUDIT, THE FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM WITH THE INFORMATION PROVIDED BY MANAGEMENT, AND REVIEWED AND APPROVED BY THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD. THE FINAL FORM 990 IS THEN CIRCULATED TO THE FULL BOARD FOR REVIEW PRIOR TO BEING FILED WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C EACH YEAR, AND ON AN AS-NEEDED BASIS, THE ORGANIZATION REQUIRES ALL TRUSTEES, OFFICERS, KEY EMPLOYEES, AND SENIOR EXECUTIVES TO COMPLETE AND SIGN A STATEMENT DISCLOSING ANY ACTUAL OR APPARENT CONFLICT OF INTEREST. THESE STATEMENTS ARE REVIEWED BY THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD, AS WELL AS BY THE CEO AND THE GENERAL COUNSEL. THE BOARD ULTIMATELY WILL DETERMINE WHETHER ANY CONFLICT OF INTEREST EXISTS, AND IF SO, IT APPOINTS A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE AND DETERMINE HOW TO MANAGE ANY SUCH CONFLICT. IN ADDITION, THE ORGANIZATION MAINTAINS A GENERAL CONFLICT OF INTEREST POLICY THAT APPLIES TO ALL EMPLOYEES. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION'S PROCESS FOR DETERMINING COMPENSATION OF ITS CEO INCLUDED REVIEW AND APPROVAL BY THE INDEPENDENT COMPENSATION AND EXECUTIVE COMMITTEES OF THE BOARD AND BY THE FULL BOARD, AS WELL AS ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, AND FORMS 990 OF OTHER ORGANIZATIONS. ALL COMPENSATION REVIEW PROCESSES ARE CONTEMPORANEOUSLY DOCUMENTED. FOR DETERMINING COMPENSATION OF ITS OTHER OFFICERS AND ITS KEY EMPLOYEES, THE ORGANIZATION USED ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, REVIEW BY THE CEO AND APPROVAL BY THE INDEPENDENT COMPENSATION COMMITTEE OF THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS FINANCIAL STATEMENTS AVAILABLE UPON REQUEST, AND ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND CODE OF CONDUCT AVAILABLE BOTH UPON REQUEST AND ON ITS WEBSITE. FORM 990, PART VI, SECTION A, LINE 1A: THE BOARD MAY DESIGNATE STANDING COMMITTEES FROM AMONG ITS MEMBERS. THESE COMMITTEES INCLUDE AN EXECUTIVE COMMITTEE, COMPRISED OF A CHAIR, VICE CHAIR, AND AT LEAST THREE ADDITIONAL MEMBERS OF THE BOARD. THE EXECUTIVE COMMITTEE MAY EXERCISE BOARD POWERS IN BETWEEN MEETINGS OF THE BOARD. FORM 990, PART VII THE ORGANIZATION'S FORM 990 IS REPORTING THE 9 MONTH TAX PERIOD ENDED DECEMBER 31, 2021. HOWEVER, THE COMPENSATION REPORTED IS FOR THE FULL 2021 CALENDAR YEAR, AS REQUIRED.